Déjà vu occurs when a novel event is experienced with an erroneous sense of familiarity. Memory researchers theorise that this arises due to an error in the processes underlying the recognition memory system. Research has indicated that there may be a link between high levels of anxiety and increased frequency and intensity of déjà vu, however there has been comparatively little characterisation of déjà vu as experienced by individuals with clinical anxiety. We used an online questionnaire to collect data from individuals self-reporting a clinical diagnosis of anxiety, as well as from age-matched controls. The Anxiety Group reported a significantly higher frequency of déjà vu episodes over the previous month than controls. They also reported experiencing déjà vu more frequently and with higher intensity during periods of high anxiety. In addition, the Anxiety Group reported finding déjà vu episodes significantly more distressing than the control group. The findings indicate that there are differences in déjà vu experienced by people reporting high levels of anxiety compared to healthy controls without an anxiety diagnosis. We discuss structural and neural mechanisms thought to underpin déjà vu in relation to these results.
Introduction
Déjà vu is a phenomenon conservatively thought to be experienced by approximately 60% of the general population (Brown, 2003) . It is typically a transitory state during which a person encountering a novel experience, such as visiting a new place, is struck by an erroneous sense of familiarity (Illman, Butler, Souchay & Moulin, 2012) . Crucially, the déjà vu experience is accompanied by insight into the false nature of this feeling of familiarity (e.g. Urquhart, Sivakumaran, Macfarlane & O'Connor, 2018) .
Whilst the mechanisms underpinning déjà vu are yet to be precisely defined, researchers have identified several potential neural correlates. Brázdil et al (2012) used source-based morphometry to compare the MRI scans of healthy participants who either had or had not experienced déjà vu. Group allocation was determined by their responses on the Inventory for déjà vu experiences assessment (IDEA; Sno et al, 1994) , a retrospective measure of déjà vu experiences. There was significantly less grey matter in several regions of the limbic-temporal network including the hippocampi and parahippocampal gyri, insular cortices, superior temporal sulci, basal ganglia and thalami in participants who had experienced déjà vu. In addition,grey matter volume in these regions correlated inversely with déjà vu frequency. These volumetric differences are consistent with grey matter reductions reported in patients with temporal lobe epilepsy (TLE, e.g. Brázdil, Mareček, Fojtíková et al, 2009; Pail, Brázdil, Mareček& Mikl, 2010) . TLE research has provided insight into the mechanisms underlying déjà vu as these experiences often feature as part of simple partial seizures. Similarities have been noted between TLE-related and 'healthy' (i.e. non-pathological) déjà vu (Warren-Gash & Zeman, 2003; Moulin 2014) in terms of the phenomenology and intensity of these episodes, although it may be that déjà vu symptoms are on a continuum between healthy and epileptic déjà vu (Perucca et al, 2017) . Labate et al (2015) compared healthy participants who had and had not experienced déjà vu and patients with benign TLE who did or did not experience déjà vu as part of their epilepsy. The TLE group with déjà vu had increased grey matter volume in the left mesio-temporal region and left visual cortex compared with TLE patients without déjà vu. The healthy déjà vu group demonstrated a different profile, principally in terms of reduced grey matter volume in the anterior insular cortex, part of the limbic system, compared to the healthy non-déjà vu group. The authors summarise that alterations in memory circuitry are present in individuals with epilepsy and déjà vu, whilst alterations are seen in emotional circuitry in healthy individuals experiencing déjà vu. symptoms and depersonalisation, and 30 individuals with TLE, aiming to compare the prevalence of a range of symptoms. Déjà vu was reported by 12/30 of the PADS and 7/30 of the TLE group. The authors also indicated that déjà vu episodes were of a longer duration in the PADS group (although this data was not presented in the article). These findings therefore indicate a possible link between symptoms associated with anxiety and a higher frequency of occurrence and longer duration of déjà vu episodes.
Interest in exploring the relationship between anxiety and déjà vu was recently revived through a case study reported by Wells et al. (2014) . A young male, presenting with high levels of anxiety, reported experiencing chronic and debilitating déjà vu.
Neurological assessment indicated no obvious underling neurological pathology, indicating that this was potentially psychogenic in nature, and that his high level of anxiety may both contribute to and result from his frequent déjà vu experiences. It is difficult to characterise the nature of the relationship between anxiety and déjà vu from this single case but, placed alongside the earlier findings of Harper and Roth (1962) , it adds to the rationale behind conducting a more extensive assessment of the déjà vu experiences of clinically-anxious patients compared to healthy controls and to further define the nature of the relationship between anxiety and déjà vu.
There is also a broader rationale for exploring the relationship between anxiety and déjà vu. There has been acknowledgement within the literature that déjà vu can be symptomatic of psychiatric disorders (Warren-Gash & Zeman, 2003 ), yet beyond a few studies which have explored déjà vu in the context of schizophrenia (Adachi et al, 1999) and mood disorders (Silberman, Post, Nurnberger, Theodore & Boulenger, 1985) , there is limited data characterising déjà vu in clinical groups besides TLE. Therefore, there remains both scope and rationale to profile déjà vu in a range of psychiatric disorders in considerably more detail than currently exists, and anxiety disorders have been highlighted as of particular interest (Illman et al, 2012; Moulin, 2014; Wells et al, 2014) . This paper presents the results of a questionnaire study assessing aspects of déjà vu, including frequency, intensity, and triggers of these episodes in two groups of participants: individuals who self-reported having a clinical diagnosis of anxiety ('Anxiety Group') and individuals who reported having no such diagnosis ('Control Group') and compared responses across these two groups. The study also included several standardised measures used to assess anxiety, stress, depression and dissociation. Based on the nascent literature in the field, we speculatively suggest that clinically anxious participants will report their déjà vu experiences as being more frequent and longer in duration than non-anxious controls.
Method

Participants
All participants were recruited online from advertisements posted on a range of sites, including anxiety websites and forums, social media and websites recruiting voluntary psychology research participants. Participants were given the choice to complete the study online or request paper copies. The majority of participants (99.4%) completed the study online. Two participants requested paper copies, which were posted to them for completion.
Demographic characteristics
A total of 352 participants completed the study. Of these, 153 participants reported having a diagnosis of clinical anxiety (23 males, 130 females, mean age = 26.8 years, SD = 9.1 years), described as the clinical anxiety group. The participants with clinical anxiety were also asked to provide their anxiety diagnosis from several alternatives taken from the DSM-IV criteria. The most frequently reported diagnosis was Generalised Anxiety Disorder (GAD; 63.9% of participants). The anxiety group also reported diagnoses of Social Phobia (28.8%), Post-Traumatic Stress Disorder (PTSD; 19.6%), Obsessive Compulsive Disorder (OCD; 13.7%), Specific Phobia A series of t-tests on our standardised measures (see below) ascertained that our Anxiety Group were significantly more anxious than our control group (see Table 1 ). In sum, the Anxiety group scored significantly higher on all measures assessing anxiety, stress, depression and dissociation.
[ Table 1 here]
Measures
The questionnaire study comprised five sub-sections 1) Demographics; 2)
Questions about anxiety and any clinical anxiety diagnoses (N.B. this section included the following question: 'On a scale of 1-5, how would you rate your overall anxiety levels compared to other people?'this is referred to as 'subjective anxiety' throughout the rest of the paper); 3) An assessment of general knowledge about déjà vu and any such experiences participants have had to date; 4) Several standardised measures to assess levels of anxiety, depression, stress, and dissociative experiences; and 5)
Questions asking more specifically about participants' déjà vu in relation to anxiety. Figure 1 presents an overview of the structure of the questionnaire and déjà vu questions. The questionnaire battery was identical in terms of content and ordering of the questions in both the online and paper versions.
Déjà vu assessment
Before answering questions about déjà vu, participants were provided with a definition: 'Déjà vu is the name we give to a strange sensation, where we feel like we have encountered something before, but we know that we have not. It might be meeting a person for the first time, going to a new place, or just having a conversation'. They were then asked two sets of questions about déjà vu. These were positioned either side of the standardised measures of anxiety, depression, stress and dissociative experiences.
Part 1 asked participants about their previous experiences of déjà vu (e.g. frequency and duration of déjà vu experiences, Figure 1 ). Part 2 included questions which focused more specifically on déjà vu in the context of anxiety (e.g. frequency of déjà vu experiences, Figure 1 ). This section also included a number of open-ended questions about déjà vu, which asked participants to elaborate on issues including: whether they ever experienced any abnormal sensations during their déjà vu experiences; whether their déjà vu experiences contained any emotional content; whether they had ever noted a connection between their déjà vu experiences and anxiety or discussed this relationship with anyone. They were also asked whether they had ever discussed their déjà vu experiences with a professional and what they perceived their attitude to be. A limited number of responses were gathered for these open-ended questions and so the analysis presented here is primarily focused on the quantitative data gathered from the questionnaire.
Standardised measures of dissociation, anxiety, stress and depression Dissociative Experiences Scale
The Dissociative Experiences Scale (DES; Bernstein & Putnam, 1993) is a 28 item self-report questionnaire assessing dissociation. An example item is 'Some people have the experience of finding themselves in a place and having no idea how they got there. Select a number to show what percentage of the time this happens to you.'
Participants select a percentage value ranging from 0-100% in 10% intervals. Higher mean scores reflect higher levels of dissociation.
Depression, Anxiety and Stress Scales
The Depression, Anxiety and Stress Scales (DASS-21) measure the dimensions of depression, anxiety and stress (Lovibond & Lovibond, 1995) . The 21-item version includes 7 statements for each of the three dimensions. Participants are asked to indicate how much each statement applied to them over the past week. An example item from the anxiety scale is 'I worried about situations in which I might panic and make a fool of myself'. Participants are asked to rate each item from on a 4-point Likert scale from 'Did not apply to me at all' to 'Applied to me very much, or most of the time'. The total score is multiplied by 2 to calculate the final score. Scores for each dimension can fall into one of 5 categories; normal, mild, moderate, severe and extremely severe (Depression: normal 0-9; mild 10-13; moderate 14-20; severe 21-27; extremely severe 28+; Anxiety: normal 0-7; mild 8-9; moderate 10-14; severe 15-19; extremely severe Participants were also asked as to whether they perceived their déjà vu experiences to be more frequent than others their age. Overall, 29% of the Anxiety Group, compared to 17% of the Control Group, felt that they experienced déjà vu more frequently than other people their age (Table 2 ).
[ Table 2 here]
Duration of déjà vu
Participants were asked to provide a text description of the typical duration of their déjà vu experiences. These descriptions were coded into seconds, minutes and hours to allow for comparison between groups. The pattern of responses did not differ significantly between the two groups (X 2 [1, N = 227] = 2.18, p = 0.34) ( Table 3 ).
[ Table 3 here]
Subjective reports of anxiety and déjà vu
Triggers of déjà vu
Participants were asked about the perceived circumstantial triggers for their déjà vu and were asked to select as many as they felt related to them. Possible responses were: locations and people (familiar and unfamiliar), conversations, recreational drugs, stress, tiredness and anxiety. Anxiety was the only trigger significantly more frequently reported by the Anxiety Group than the Control Group (Table 4 ).
[ Table 4 here]
Distress levels
The Anxiety Group reported déjà vu as causing them undue distress compared to controls (X 2 [1, N = 331] = 6.46, p = 0.01) suggesting that experiencing déjà vu affects this group in a different manner compared to healthy controls (Table 5 ).
[ Table 5 here]
Déjà vu during periods of high anxiety or stress
Participants were asked about their déjà vu experiences during periods of both minimal and high anxiety/stress. The Anxiety Group reported their déjà vu experiences as significantly more frequent (M = 2.44, SD = 1.04) than controls (M = 2.09; SD = 0.87; t285.96 = -3.39, p = 0.001) during periods of high anxiety/stress. They also reported that these déjà vu experiences as significantly more intense (M = 3.00, SD = 1.19) than controls (M = 2.45, SD = 1.14; t340 = 4.28, p = 0.00002). There were no group differences when asked identical questions regarding periods of minimal anxiety/stress.
Emotionality of déjà vu experiences
The Anxiety Group reported their déjà vu experiences as containing emotional content more frequently than controls [X 2 (1, N = 332) = 8.76, p = 0.003]. They also rated this content as significantly more emotional (M = 2.54, SD = 1.44) than controls (M = 2.00, SD = 1.39; t233.63 = 3.38, p = 0.001). Participants also had the opportunity to provide some qualitative information regarding the nature of their déjà vu and the emotions they experienced. The Anxiety Group described a range of accompanying emotions, including anxiety, stress and confusion (e.g. 'I become very frightened and as if I am stuck in the room in which I am experiencing it') but also more positive emotions such as curiosity, excitement and nostalgia (e.g. '..it makes me feel like I'm special because I'm experiencing something extraordinary', and sometimes both at once (e.g. 'typically very nostalgic emotions, but paired with confusion or detached distress/panic due to the fact that I cannot remember the circumstances of first experiencing the emotion'). Control Group participants reported a similar range of positive and negative emotions, but in addition to this several participants in this group did not feel that any emotion was associated with their déjà experiences e.g. 'usually (a) very neutral feeling'.
Correlational Analyses
Thus far, our data points to our Anxiety Group having more frequent déjà vu (especially during periods of high anxiety), and déjà vu which is triggered by anxiety and is perceived as being more distressing. However, within each group there are differences in how frequently the groups report having déjà vu (Figures 2 and 3) . To examine the characteristics of anxiety triggered déjà vu and anxiety and déjà vu more generally we carried out correlational analyses. We carried out a series of correlations separately in each group (Tables 6 and 7) .
The uncorrected correlations (Tables 6 and 7) are mostly significant, given our large sample sizes. Here we will focus on correlations within the Anxiety Group and consider r values of .3 and above as medium size effects (Cohen, 1988 ) and therefore of interest. Firstly, our measures of déjà vu are internally consistentwith a correlation (r=.77) between the questions about monthly and yearly frequency. The self-rated frequency of déjà vu in the past month correlates with the SAS measure of anxiety (r=.30), and although significant correlations are found for all the other anxiety and depression measures (except the subjective anxiety measure), these are not of a comparable effect size. Thus, we are fairly confident in saying that amongst our anxious sample, it is those who experience higher levels of anxiety who have higher levels of déjà vu. This pattern is repeated in the question about frequency of déjà vu in the past year, with the SAS giving the highest correlation coefficient (r=.36). Perhaps of most interest, within the Anxiety Group, it appears that those with highest levels of déjà vu are those with higher reports of dissociative experiences (rs of .27 and .38 for monthly and yearly frequency respectively). The DES itself correlates with most of the anxiety measures with high r values. Within the Control Group, a similar pattern is found, with strong correlations between many of the tasks. Again, SAS seems to be best correlated with reports of déjà vu frequency, and although not quite reaching a medium effect size, there is a correlation between the DES and the monthly and yearly ratings of déjà vu frequency (rs .27 and .25 respectively). In summary, we have been deliberately cautious in describing the patterns of correlations in our data, but it appears that déjà vu experiences are associated with higher scores on measures of anxiety and dissociative experiences.
[ Table 6 here] [ Table 7 here]
Discussion
We found that participants with clinical anxiety reported a higher frequency of déjà vu episodes than a group of healthy age-matched controls, although there were no group differences in the duration of these episodes. The Anxiety Group also reported their déjà vu experiences as being more frequent and of a higher intensity during periods of high anxiety than controls. When asked to identify circumstances or triggers they associated with the onset of déjà vu, these were broadly similar across the two groups, but the Anxiety Group were significantly more likely than controls to report anxiety as a trigger. They were also significantly more likely to report these episodes contained emotional content. When asked about their feelings towards déjà vu, the Anxiety Group reported finding these as significantly more distressing than controls.
Perhaps unsurprisingly then, measures of anxiety correlated with the frequency of déjà vu experience.
It has long been established that déjà vu involves memory-related circuitry (e.g.
see Hughlings-Jackson, 1881; Penfield & Perot, 1963; Halgren, Walter, Cherlow & Crandall, 1978) but research has also long-since implicated emotional circuitry in déjà vu (e.g. Gloor, Oliver & Quesney, 1982) . Structural differences in memory and emotion-related circuitry are apparent when comparing healthy individuals who experience déjà vu and individuals with TLE and déjà vu (Labate et al, 2015) , and indeed research comparing the phenomenology of déjà vu in these two groups remains somewhat inconclusive as to the extent to which they are the same (Warren-Gash & Zeman, 2001; Moulin, 2014; Perucca et al, 2017) . Perhaps then, the phenomenological differences we report between our controls and the Anxiety Group also reflect underlying structural differences in memory and/or emotion-related circuitry. Whilst this is beyond the scope of this paper, it would be of interest to determine whether there are any structural markers which differentiate these two groups.
Oscillatory activity may also play a role in the group differences we observe Theta oscillations are known to play a role in both memory-related processes (e.g. Mormann et al, 2008; Osipova et al, 2006; Sederberg, Kahana, Howard, Donner & Madsden, 2003) , but they also play a role in anxiety-related processing (e.g. Cornwell, Arkin, Overstreet, Carver, & Grillon, 2012; Khemka, Barnes, Dolan & Bach, 2017 ). In addition, O'Connor et al (2010) speculatively proposed theta oscillations could play a role in déjà vécu, a clinical manifestation of déjà vu. If theta is involved in the generation of déjà vu perhaps the differences we observed between the Anxiety Group and controls reflect underlying anxiety-related differences in oscillatory activity.
We found that whilst there were differences in the frequency of déjà vu episodes, and the perceived distress they caused, there was no difference in duration of déjà vu when comparing the two groups. However, one of the key limitations in déjà vu research is that it is largely retrospective in nature, which is problematic when aiming to collect accurate data about these subjective experiences. We attempted to address this issue by encouraging participants who completed the study discussed here to complete a brief follow-up immediately after their next déjà vu episode. This follow-up required participants to complete the Impact of Event Scale (Horowitz, Wilner & Alvarez, 1979) , typically used to assess stress reactions for traumatic events. Low numbers of respondents precluded us from engaging in a detailed analysis, but we did find that the Anxiety Group scored significantly higher than controls on the intrusion subscale, indicating that these participants experienced intrusive thoughts about their déjà vu following that specific episode. This is interesting when considering that in this paper we report Anxiety Group found déjà vu to be significantly more distressing than the Control Group did. It would therefore be useful to further develop this follow-up approach, asking some more detailed questions regarding those recently-experienced déjà vu experiences. It would also be interesting to gather detailed data on vividness, as there is some retrospective data indicating that this can differ between clinical groups (Harper & Roth, 1962) . Another issue we believe to be of interest is determining the relationship between déjà vu intensity and frequency, and whether the nature of this relationship would differ between clinically anxious individuals and controls.
We have added to the evidence base about clinical anxiety and déjà vu. It is commonly asserted there is a relationship between déjà vu and stress (e.g. Brown, 2003) , and more recently research has indicated that there may be differences in the frequency and intensity of déjà vu experienced by people with clinical anxiety. We therefore believe that this paper adds important quantitative support, which has been previously lacking, to the existence of such relationships. This paper therefore contributes not only to the pre-existing body of déjà vu research, but also makes a clinically-relevant contribution. Towards the end of this study we asked participants whether they have ever discussed their déjà vu experiences when with a medical professional. In a few instances, participants reported that they had, and that they were told anxiety and déjà vu are associated (e.g. 'yes, (I) was told it was common for people with anxiety'). In presenting novel findings which confirm the existence of such a relationship, our findings therefore strengthen the validity of such discussions between patients and clinicians.
In summary, we report the main findings from the first large-scale study profiling déjà vu in anxiety. It would appear that déjà vu is more frequently experienced by people with clinical anxiety, and that déjà vu experiences cause significantly more distress than they do in healthy controls. Understanding these group differences may be of use to clinicians when considering the potential impact of déjà vu symptoms upon the psychological wellbeing of individuals with anxiety disorders. Note: X 2 = Chi Squared, df = degrees of freedom, p = significance value, Bonferroni adjusted alpha levels of p < 005. 
